PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426,059 | -43.9% | 19,012 | +1.9% | 0.00% | -33.3% |
| Q2 2023 | $758,902 | -16.4% | 18,660 | -0.5% | 0.01% | -25.0% |
| Q1 2023 | $908,008 | +30.9% | 18,745 | +3.2% | 0.01% | +14.3% |
| Q4 2022 | $693,473 | -20.8% | 18,168 | +4.1% | 0.01% | -22.2% |
| Q3 2022 | $876,000 | +25.7% | 17,447 | +0.2% | 0.01% | +28.6% |
| Q2 2022 | $697,000 | +8.6% | 17,405 | +1.2% | 0.01% | +40.0% |
| Q1 2022 | $642,000 | -5.7% | 17,200 | +0.6% | 0.01% | 0.0% |
| Q4 2021 | $681,000 | +5.9% | 17,103 | -1.0% | 0.01% | 0.0% |
| Q3 2021 | $643,000 | -11.6% | 17,272 | +0.4% | 0.01% | -16.7% |
| Q2 2021 | $727,000 | -14.1% | 17,204 | -3.8% | 0.01% | -14.3% |
| Q1 2021 | $846,000 | -21.5% | 17,877 | +1.2% | 0.01% | -30.0% |
| Q4 2020 | $1,078,000 | +35.1% | 17,671 | +3.5% | 0.01% | +25.0% |
| Q3 2020 | $798,000 | +25.7% | 17,074 | +36.4% | 0.01% | -11.1% |
| Q2 2020 | $635,000 | +9.3% | 12,520 | -3.9% | 0.01% | -10.0% |
| Q1 2020 | $581,000 | – | 13,022 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,155,000 | $101,285,000 | 11.24% |
| RTW INVESTMENTS, LP | 3,275,591 | $153,953,000 | 9.22% |
| Asymmetry Capital Management, L.P. | 173,010 | $8,131,000 | 7.51% |
| GREAT POINT PARTNERS LLC | 717,458 | $33,721,000 | 5.26% |
| Ghost Tree Capital, LLC | 500,000 | $23,500,000 | 5.00% |
| MAK CAPITAL ONE LLC | 221,723 | $10,421,000 | 3.41% |
| Opaleye Management Inc. | 180,000 | $8,460,000 | 2.15% |
| Avoro Capital Advisors LLC | 684,000 | $32,148,000 | 1.48% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,616,998 | $75,999,000 | 1.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $9,870,000 | 1.13% |